The Scientific Advisors at Candel Therapeutics provide expert guidance on the development and implementation of oncolytic viral immunotherapies. They leverage their extensive knowledge in cancer research to inform strategic decisions, collaborate with cross-functional teams, and ensure that clinical programs align with the latest scientific advancements and regulatory standards. Their role is crucial in translating innovative ideas into effective therapies that aim to improve patient outcomes.
View all